Rainer Strotmann

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Ejection Fraction

Tyrosine Kinase

Top Venues

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Wenyuan Xiong, Sofia Friberg Hietala, Joakim Nyberg, Orestis Papasouliotis, Andreas Johne, Karin Berghoff, Kosalaram Goteti, Jennifer Dong, Pascal Girard, Karthik Venkatakrishnan, Rainer Strotmann
Exposure-response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendations. Cancer chemotherapy and pharmacology 90 (1) (2022)